Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-004218-34Phase 3Terminated
Phase 3, single-arm trial of niacin in coronary arteriosclerosis and lipid disorder, sponsored by Department of Cardiology, University Hospital Aachen. Primary endpoint: Myocardial blood flow and flow reserve change. Started Feb 2006; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-004218-34.